The validity of arming oncolytic viruses with either RNA-based inhibitor of epigenetic silencing or apoptosis inducing gene was further supported in that viruses that only express shRNA against histone deacetylase 1 or the TP73 gene lead to tumor regression in two or three out of eight mice, respectively. Here, TP73 is linked to neoplasm.